Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation
Tarih
2007Yazar
Can, Günay
KARABULUT, A.
ALBAYRAK, S.
ONAT, A.
HERGENC, G.
YAZICI, M.
Üst veri
Tüm öğe kaydını gösterÖzet
Objectives: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.
Koleksiyonlar
- Makale [92796]